SXTP
Income statement / Annual
Last year (2025), 60 Degrees Pharmaceuticals Inc's total revenue was $1.01 M,
an increase of 65.49% from the previous year.
In 2025, 60 Degrees Pharmaceuticals Inc's net income was -$7.37 M.
See 60 Degrees Pharmaceuticals Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$1.01 M |
$607.57 K |
$253.57 K |
$223.21 K |
$1.16 M |
$2.18 M |
| Cost of Revenue |
$781.70 K
|
$384.77 K
|
$474.55 K
|
$432.37 K
|
$850.74 K
|
$702.99 K
|
| Gross Profit |
$223.78 K
|
$222.81 K
|
-$220.98 K
|
-$209.16 K
|
$309.60 K
|
$1.48 M
|
| Gross Profit Ratio |
0.22
|
0.37
|
-0.87
|
-0.94
|
0.27
|
0.68
|
| Research and Development Expenses |
$2.11 M
|
$4.99 M
|
$691.77 K
|
$525.56 K
|
$5.51 M
|
$806.68 K
|
| General & Administrative Expenses |
$6.28 M
|
$5.02 M
|
$4.24 M
|
$1.30 M
|
$1.12 M
|
$1.46 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.28 M
|
$5.02 M
|
$4.24 M
|
$1.30 M
|
$1.12 M
|
$1.46 M
|
| Other Expenses |
-$403.62 K
|
-$73.77 K
|
$0.00
|
-$288.00 K
|
-$5.19 M
|
-$368.11 K
|
| Operating Expenses |
$7.98 M
|
$9.94 M
|
$4.93 M
|
$1.54 M
|
$1.43 M
|
$1.90 M
|
| Cost And Expenses |
$8.76 M
|
$10.32 M
|
$5.41 M
|
$1.97 M
|
$2.28 M
|
$2.60 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$7.81 K
|
$7.91 K
|
$2.29 M
|
$3.99 M
|
$3.17 M
|
$2.68 M
|
| Depreciation & Amortization |
$82.87 K
|
$63.75 K
|
$100.37 K
|
$78.79 K
|
$71.79 K
|
$27.87 K
|
| EBITDA |
-$7.28 M |
-$7.88 M |
-$1.43 M |
-$2.11 M |
-$1.01 M |
-$341.17 K |
| EBITDA Ratio |
-7.24
|
-12.98
|
-5.63
|
-9.45
|
-0.87
|
-0.16
|
| Operating Income Ratio |
-7.72
|
-15.99
|
-20.33
|
-7.84
|
-0.97
|
-0.19
|
| Total Other Income/Expenses Net |
$390.25 K
|
$1.76 M
|
$1.34 M
|
-$4.43 M
|
-$3.14 M
|
-$2.63 M
|
| Income Before Tax |
-$7.37 M
|
-$7.96 M
|
-$3.81 M
|
-$6.18 M
|
-$4.26 M
|
-$3.05 M
|
| Income Before Tax Ratio |
-7.33
|
-13.09
|
-15.04
|
-27.68
|
-3.67
|
-1.4
|
| Income Tax Expense |
$0.00
|
$250.00
|
$250.00
|
$500.00
|
$1.00 K
|
$1.00 K
|
| Net Income |
-$7.37 M
|
-$7.95 M
|
-$3.77 M
|
-$6.18 M
|
-$4.25 M
|
-$3.03 M
|
| Net Income Ratio |
-7.33
|
-13.08
|
-14.85
|
-27.69
|
-3.66
|
-1.39
|
| EPS |
-11.73 |
-74.2 |
-3.8 |
-4.28 |
-2.96 |
-2.08 |
| EPS Diluted |
-11.73 |
-74.2 |
-3.8 |
-4.28 |
-2.96 |
-2.08 |
| Weighted Average Shares Out |
$670.21 K
|
$113.65 K
|
$990.07 K
|
$1.45 M
|
$1.45 M
|
$1.45 M
|
| Weighted Average Shares Out Diluted |
$670.21 K
|
$113.65 K
|
$990.07 K
|
$1.45 M
|
$1.45 M
|
$1.45 M
|
| Link |
|
|
|
|
|
|
